# Yonghua Capital

> Yonghua Capital is a VC fund backing Manufacturing and Health Care. See 169 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 169
- Last investment: Jul 2026
- Lead investor: 32%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/%E4%B8%8A%E6%B5%B7%E6%B6%8C%E9%93%A7%E6%8A%95%E8%B5%84%E7%AE%A1%E7%90%86%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8
- Website: http://www.yonghuacapital.com.cn/

Yonghua Capital is a VC fund in Shanghai focused on Manufacturing and Health Care. Shanghai Chung Hua Investment Management Co., Ltd. is specialized in Yongjin Group's equity investment management platform. Total investment scale Chung Hua invest over 6 billion yuan, it has invested in more than 80 outstanding enterprises, of which more than 40 enterprises have been successfully listed. Currently Chung Hua investment teamcovering the major cities Beijing, Shanghai, Shenzhen, Xiamen, Hangzhou, Changsha, Chengdu, etc., and in many industries new energy, environmental protection, consumer goods, TMT, agriculture and other in-depth research team.

## Contacts

5 contacts available for Yonghua Capital. Shizune tracks 4 team members at Yonghua Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/yongyong-investment?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $142k–$15M |
| Series A | $1.4M–$48M |
| Series B | $2.8M–$100M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 25 | 15% |
| Health Care | 19 | 11% |
| Education | 17 | 10% |
| Artificial Intelligence | 17 | 10% |
| Software | 15 | 9% |

120 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 60 | 36% |
| Series B | 33 | 20% |
| Seed | 21 | 12% |
| Angel | 15 | 9% |
| Series C | 10 | 6% |

11 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 117 | 69% |
| United States | 9 | 5% |
| Canada | 2 | 1% |
| Japan | 1 | 1% |
| Belgium | 1 | 1% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Li Yang | Executive Director | 0 | https://shizune.co/investors/profile/li-yang-2 |
| Moses Zhao | Co-Founder & Managing Director | 1 | https://shizune.co/investors/profile/moses-zhao |
| Zhang Chen | Deputy Director | 1 | https://shizune.co/investors/profile/zhang-chen-8e3e |
| Zhang Shuai | Partner | 1 | https://shizune.co/investors/profile/zhang-shuai-77ea |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Biyi Laser | Biyi Laser refers to a technology that uses laser beams as information carriers to directly transmit voice, data, and images at high speed and in a bidirectional manner, offering advantages such as high bandwidth, strong anti-interference capability, enhanced security, and flexible deployment for applications in communications, data transmission,and advanced information systems. |  | Series B | Jul 29, 2026 |  |
| Shexu Technology | Established in 2020, Shanghai Shexu Technology Co., Ltd. is an AI-driven industrial design software R&D technology enterprise and design service provider. The company has a professional scientific research and technical team, and has independently developed automatic industrial design software based on AI computing engine. The design softwarehas been widely used in the field of automotive industry equipment, significantly improving the design efficiency of industrial machinery designers. | $14.8M | Series B | Jul 23, 2026 |  |
| Tianhu Technology | Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider. |  | Series A | Jul 13, 2026 |  |
| Shanmu SHANMU | Shanmu SHANMU is a micro medical robot specialist who uses self-developed digital microfluidic chipsets and artificial intelligence algorithms. The robot can continuously check the metabolic components in urine, establishing a link between the user's health status and disease and intelligently establishing multiple disease management cycles. | $14.7M | Series A | May 06, 2026 |  |
| Minyue Keji | Minyue provides intelligent welding solutions that include a laser vision seam tracking system, a light vision sensor, and off-line programming software for industrial robots. They solve the programming problems of industrial robots in various complex applications, and the company has developed offline programming software for industrial robots. |  | Series B | Apr 16, 2026 |  |
| Tianhu Technology | Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider. | $29M | Series A | Mar 16, 2026 |  |
| C12.ai | C12.ai is an artificial intelligence company that develops AI-powered drug discovery and laboratory automation platforms for the biotechnology and life sciences sectors. Its solutions combine machine learning, data science, and automated experimentation to support research, molecular discovery, and scientific decision-making across pharmaceuticaland biotech applications. | $7.3M | Seed | Mar 12, 2026 |  |
| UniX AI | UniX AI possesses advanced research and development capabilities in the domain of embodied intelligent robotics. The team comprises specialists from various disciplines, including structural engineering, electronics, algorithms, and deep learning. This technology company focuses on enhancing the robot's ability to generalize in intricatescenarios. | $43.7M | Venture - Series Unknown | Mar 02, 2026 |  |
| Myactuator | Myactuator is an intelligent technology company that specializes in the design, simulation, and development of robot actuators and control systems. |  | Series A | Mar 02, 2026 |  |
| Star Earth Exploration | Star Earth Exploration is a provider of satellite security products and security operation services. |  | Angel | Feb 25, 2026 |  |

10 of 169 investments shown.

## Co-investors
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 6 deals together
- [Legend Capital](https://shizune.co/investors/profile/legend-capital) — VC Fund, 6 deals together
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 5 deals together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 5 deals together
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund, 5 deals together
- [Oriza Seed Capital (Oriza Yuandian)](https://shizune.co/investors/profile/oriza-seed-capital) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [All Investors in China](https://shizune.co/investors/investors-china)
- [All VC Funds in China](https://shizune.co/investors/vc-funds-china)
- [SaaS Investors in China](https://shizune.co/investors/saas-investors-china)
- [SaaS VC Funds in China](https://shizune.co/investors/saas-vc-funds-china)
- [Software Investors in China](https://shizune.co/investors/software-investors-china)
- [Software Investors in Asia](https://shizune.co/investors/software-investors-asia)

## FAQ

### What does Yonghua Capital invest in?

Yonghua Capital invests primarily in Manufacturing, Health Care and Education startups, most often at Series A and Series B stage. Most of the 169 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Yonghua Capital's check size?

Yonghua Capital typically joins rounds of $142k–$15M at Seed, $1.4M–$48M at Series A and $2.8M–$100M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Yonghua Capital participates in.

### How do I contact Yonghua Capital?

Public channels for Yonghua Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Yonghua Capital?

The team at Yonghua Capital includes Li Yang (Executive Director), Moses Zhao (Co-Founder & Managing Director) and Zhang Chen (Deputy Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co